View abstract

TitreSafety of intra-vitreal injections : a 3-year experience
Butto evaluate the safety of intra-vitreal injections .
Méthodesretrospective study of patients treated by a standart protocole of intra-vitreal injection. Evaluation of per and post-operative complications.
Résultats 1523 eyes received an intra-vitreal injection over a period of 32 months. Bevacizumab was injected in 843 eyes, ranibizumab in 402 eyes, pegaptanib in 223 eyes and triamcinolone acetonide in 55 eyes. Bulbar ecchymosis was frequent, allergic reaction to topical drops or povidone iodine was reported, reversible central artery occlusion occurred in 3 eyes (0.2 %), pseudo-uveitis in 1 eye (0.065 %), uveitis in 2 eyes (0.13 %) and endophthalmitis in 1 eye (0.065 %). No cases of vitreal hemorraghe, posterior capsule rupture, lens injury, retinal detachment or retinal tear were described.
Conclusion In our practice, complications of intra-vitreal injections are rare and often reversible. Endophthalmitis is exceptional and occurred in only 1 eye (0.065 %). Intra-vitreal injections are a safe procedure when standart protocole is used.
Auteur 1
NomGUAGNINI
InitialesAP
InstitutCliniques Universitaires Saint-Luc, UCL
VilleBruxelles
Auteur 2
NomSnyers
InitialesB
InstitutCliniques Universitaires Saint-Luc, UCL
VilleBruxelles
Auteur 3
NomKozyreff
InitialesA
InstitutCliniques Universitaires Saint-Luc, UCL
VilleBruxelles
top ^